(Z)-1-(1,3-dioxoisoindol-2-yl)ethoxyimino-[4-(hydroxymethyl)piperidin-1-yl]-oxidoazanium
C16H20N4O5 — CID 118237813
Data last refreshed: (MolForge compound catalog, from PubChem)
About (Z)-1-(1,3-dioxoisoindol-2-yl)ethoxyimino-[4-(hydroxymethyl)piperidin-1-yl]-oxidoazanium
(Z)-1-(1,3-dioxoisoindol-2-yl)ethoxyimino-[4-(hydroxymethyl)piperidin-1-yl]-oxidoazanium (PubChem CID 118237813) has the molecular formula C16H20N4O5 and a molecular weight of 348.36 g/mol. Its IUPAC name is (Z)-1-(1,3-dioxoisoindol-2-yl)ethoxyimino-[4-(hydroxymethyl)piperidin-1-yl]-oxidoazanium.
Molecular Properties
| Compound Name | (Z)-1-(1,3-dioxoisoindol-2-yl)ethoxyimino-[4-(hydroxymethyl)piperidin-1-yl]-oxidoazanium |
|---|---|
| PubChem CID | 118237813 |
| Molecular Formula | C16H20N4O5 |
| Molecular Weight | 348.36 g/mol |
| Exact Mass | 348.14 |
| IUPAC Name | (Z)-1-(1,3-dioxoisoindol-2-yl)ethoxyimino-[4-(hydroxymethyl)piperidin-1-yl]-oxidoazanium |
| SMILES | CC(O/N=[N+](\[O-])N1CCC(CO)CC1)N1C(=O)c2ccccc2C1=O |
| InChI | InChI=1S/C16H20N4O5/c1-11(19-15(22)13-4-2-3-5-14(13)16(19)23)25-17-20(24)18-8-6-12(10-21)7-9-18/h2-5,11-12,21H,6-10H2,1H3/b20-17- |
| InChIKey | OFMHLFQCFPCTMH-JZJYNLBNSA-N |
| XLogP | 1.14 |
| TPSA | 108.51 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 25 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 348.36 |
| LogP ≤ 5 | 1.14 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'azo_A(324)', 'substructure': 'N/A'}, {'alert_name': 'diazo_group', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}, {'alert_name': 'phthalimide', 'substructure': 'N/A'}, {'alert_name': 'quaternary_nitrogen_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118237813 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.